Search

Your search keyword '"Karamani, Angeliki"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Karamani, Angeliki" Remove constraint Author: "Karamani, Angeliki"
17 results on '"Karamani, Angeliki"'

Search Results

1. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

2. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

3. Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial

4. Body composition and lung cancer-associated cachexia in TRACERx

5. The evolution of non-small cell lung cancer metastases in TRACERx

6. The evolution of lung cancer and impact of subclonal selection in TRACERx

7. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

8. Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission

9. Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission

10. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

11. Passive Prophylactic Administration with a Single Dose of Anti–Fel d 1 Monoclonal Antibodies REGN1908–1909 in Cat Allergen–induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

12. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

13. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

14. Short Course of Lolium Perenne Peptides (LPP) Immunotherapy Induces IL-35 + T Regulatory Cells (iTr35) that Promote B Regulatory Cells (Bregs) and Blocking Antibodies

15. Short Course of Lolium Perenne Peptides (LPP) Immunotherapy Deletes Circulating IL-4 + IL-21 + T follicular helper cells and Induces FoxP3 + T follicular regulatory cells: A Randomized Controlled Trial

16. Short Course of Lolium Perenne Peptides (LPP) Immunotherapy Induces IL-35+ T Regulatory Cells (iTr35) that Promote B Regulatory Cells (Bregs) and Blocking Antibodies.

17. Short Course of Lolium Perenne Peptides (LPP) Immunotherapy Deletes Circulating IL-4+IL-21+ T follicular helper cells and Induces FoxP3+ T follicular regulatory cells: A Randomized Controlled Trial.

Catalog

Books, media, physical & digital resources